• Aucun résultat trouvé

Good enough

N/A
N/A
Protected

Academic year: 2022

Partager "Good enough"

Copied!
1
0
0

Texte intégral

(1)

470

Canadian Family PhysicianLe Médecin de famille canadien Vol 55: may • mai 2009

Letters

Correspondance

The top 5 articles

read on-line at cfp.ca last month

1. Rx Files: Taking the stress out of acne manage- ment (March 2009)

2. Clinical Review: Approach to management of suspected rabies exposures. What primary care physicians need to know (March 2009)

3. Clinical Review: Complementary and alterna- tive medicine for treatment of irritable bowel syndrome (February 2009)

4. Editorial: In defence of a “good-enough” family physician (March 2009)

5. Clinical Review: Home blood testing for celiac disease. Recommendations for management (February 2009)

Good enough

A

s a physician and life coach, I read the article “To be good enough” by Drs Ratnapalan and Batty1 with great interest. Ironically, physicians, like other profes- sionals, are often driven by a compulsion to be perfect, yet seldom slow down to examine the quality of their lives and practices. But busy people cannot afford not to take time to make intentional decisions about how they will bring their personal and professional lives in line with their ideals. Questions we doctors need to ask ourselves from time to time include the following: What does good enough mean to me? What do I value most, personally and professionally? What boundaries must I establish to protect what I value? In light of my tal- ents and skills, in what way can I affect the lives of my patients? What is my vision of an ideal life or practice?

How will I get there?

A trusted partner, such as an insightful friend or professional life coach, can help a person gain self-awareness by asking such questions, then help cre- atively apply the insights, maintain focus, and over- come resistance to change through objective feedback, encouragement, and accountability.

—W. Joseph Askin MD FCFP CLC Calgary, Alta

Reference

1. Ratnapalan S, Batty H. To be good enough. Can Fam Physician 2009;55:239- 40 (Eng), 241-2 (Fr).

Worth doing

W

hen I attended University of Ottawa in Ontario many years ago, we had a guest lecturer in anat- omy (who happened to be the author of our textbook), who quoted G.K. Chesterton: “When a thing is worth doing, it’s worth doing poorly.” At the time, I probably didn’t know what it meant, but now I live by that say- ing. As a rural physician for more than 3 decades, I have done many things poorly, but I hope they were all worth doing. It’s great to have been freed from the tyranny of perfection! Thanks for the practical support.1

—Art Wiebe MD Kincardine, Ont

Reference

1. Ratnapalan S, Batty H. To be good enough. Can Fam Physician 2009;55:239- 40 (Eng), 241-2 (Fr).

Side effects and risks of rabies vaccine

I

thought the article “Approach to management of sus- pected rabies exposures”1 was extremely helpful and practical. The absence of any mention of the potential risks and side effects of both the vaccine and the immune globulin is the only major weakness of the article.

Hence, my obvious question is, what are the respec- tive risk and side effects I should disclose to patients

before administrating the vaccine and the immune globulin?

—Olivier Sabella MD CM Montreal, Que

Reference

1. Grill AK. Approach to management of suspected rabies exposures. Can Fam Physician 2009;55:247-51.

Response

T

he most common side effects associated with the administration of the rabies vaccine are local reac- tions, such as pain, redness, swelling, and induration at the injection site. Mild systemic reactions, including headache, nausea, abdominal pain, myalgia, and dizzi- ness have also been reported in up to 40% of recipients.

Systemic allergic reactions (eg, urticaria, angioedema, fever) as well as anaphylactic reactions are rare. Local pain and low-grade fever might follow the administra- tion of rabies immune globulin.1,2

It is important to emphasize that considering the rabies virus is fatal once symptoms develop, the benefits of administering both the rabies vaccine and immune globulin to a patient with a suspected exposure far out- weigh any risks.

—Allan Grill MD CCFP MPH Toronto, Ont

References

1. National Advisory Committee on Immunization, Rabies vaccine. In:Canadian immunization guide. 7th ed. Cat No HP40-3/2006E. Ottawa, ON: Public Health Agency of Canada; 2006. p. 285-97. Available from: www.phac-aspc.gc.ca/

publicat/cig-gci/index-eng.php. Accessed 2009 Jan 21.

2. Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, et al. Rabies prevention—United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008;57(RR-3):1-28. Available from: www.cdc.gov/mmwr/preview/

mmwrhtml/rr5703a1.htm. Accessed 2009 Jan 21.

Références

Documents relatifs

global practices in relation to secret detention in the context of countering terrorism, whereby it is clearly affirmed that “every instance of secret detention

Our research showed that an estimated quarter of a million people in Glasgow (84 000 homes) and a very conservative estimate of 10 million people nation- wide, shared our

A diagnosis of rabies in a patient suspected of having the disease is valuable for multiple reasons, including: specific characterization of the causative agent and of the

18–26 Speci fi cally, and in brief, we exam- ined DASH data against published criteria for: (1) data completeness ( percent missing data for each item 21 ); (2) scaling

State transfer faults may also be masked, though to mask a state transfer fault in some local transition t of M i it is necessary for M to be in a global state that leads to one or

We tested for two additional contrasts an- alyzed by Smolka et al.: the difference in priming strength between Transparent and Opaque Deriva- tion (not significant in either

To obtain laboratory confirmation of rabies infection, different clinical specimens from each patient were sent to the World Health Organisation (WHO) Collaborating Center for

Among individuals who received PEP during the study period, 87,518 (82.4%) were exposed in mainland France (free of rabies in non-flying terrestrial mam- mals but enzootic for